| Name | Clorprenaline hydrochloride |
| Description | Clorprenaline hydrochloride (Clorprenaline HCl) is a beta-2 adrenergic agonist with bronchodilator activity. |
| In vitro | The linear ranges 8.0-1.6 ×103 ng/mL for Clorprenaline in a single chromatographic run, the detection limits 3.0 ng/mL for Clorprenaline. [1] Clorprenaline is a bronchodilator that has been separated by CE based on affinity-interaction or with charged CD-CZE sulfobuthylether (SBE)-β-CD or β-CD-phosphate with resolution greater than 1.2. Clorprenaline is separated in optimum condition of 60 mM HP-β-CD. [2] Clorprenaline hydrochloride (a), bromhexine hydrochloride (b) and decloxizine hydrochloride (c) are three main components in clorprenaline compound tablet. [3] |
| In vivo | In a single chromatographic run, the linear range of clorprenaline was 8.0-1.6 × 103 ng/mL, with a limit of detection of 3.0 ng/mL.[1] Clorprenaline is a bronchodilator that has been separated by affinity-interaction-based CE or charged CD-CZE sulfobutyl ether (SBE)-β-CD or β-CD -phosphates at a resolution greater than 1.2. Clorprenaline was separated under optimal conditions at 60 mM HP-β-CD. [2] Clorprenaline hydrochloride, bromhexine hydrochloride, and deslorohydroxyzine hydrochloride are the three main ingredients of Clorprenaline compound tablets. [3] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | Ethanol : 47 mg/mL (187.9 mM)
H2O : 46 mg/mL (183.9 mM)
DMSO : 55 mg/mL (219.86 mM)
|
| Keywords | Clorprenaline hydrochloride | Clorprenaline Hydrochloride | Beta Receptor | NSC-334693 | Inhibitor | inhibit | Adrenergic Receptor | NSC334693 | Clorprenaline |
| Inhibitors Related | Olanzapine | Mirtazapine | Octopamine hydrochloride | Gemfibrozil | Dexmedetomidine hydrochloride | Phenylephrine hydrochloride | Isoprenaline hydrochloride | Amitriptyline hydrochloride | Trazodone hydrochloride | Mianserin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Anti-Obesity Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
United States
